Keratinocyte cancer with incidental perineural invasion: A registry analysis of management and 5-year outcomes.


Journal

The Australasian journal of dermatology
ISSN: 1440-0960
Titre abrégé: Australas J Dermatol
Pays: Australia
ID NLM: 0135232

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 31 07 2019
revised: 20 02 2020
accepted: 14 03 2020
pubmed: 15 4 2020
medline: 6 7 2021
entrez: 15 4 2020
Statut: ppublish

Résumé

Perineural invasion within keratinocyte cancer is a hallmark of tumour aggression, and a definitive treatment paradigm for this condition remains undetermined. Our aim was to investigate the treatment and outcomes of keratinocyte cancer with incidental perineural invasion within two skin cancer databases to refine treatment protocols. We retrospectively assessed the Queensland Perineural Invasion Registry for surgery, histopathology, adjuvant radiotherapy and recurrence of keratinocyte cancer five years post-definitive treatment. We also reviewed the Princess Alexandra Hospital Head and Neck clinical perineural invasion database, specifically looking at surgical margins and adjuvant radiotherapy of cutaneous squamous cell carcinoma (cSCC) with incidental perineural invasion in the primary lesion. There was no recurrence at 5 years in the Perineural Invasion Registry. Basal cell carcinoma (BCC) lesions with nerves <0.1 mm were more commonly treated with surgery alone, compared to lesions with nerves ≥0.1 mm which were offered adjuvant radiotherapy. Of the total BCC lesions with incidental perineural invasion, those with perineural margins ≥5 mm and peripheral tumour margins ≥3 mm were predominantly treated with surgery alone. Eighty-nine per cent of cSCC lesions with incidental perineural invasion were treated with surgery and adjuvant radiotherapy. Surgery alone is suitable for BCC lesions with incidental perineural invasion. The majority of BCC lesions achieved ≥5 mm perineural and ≥3 mm peripheral tumour margins. Future research can guide if adjuvant radiation is required for BCC with perineural invasion. The treatment of cSCC with incidental perineural invasion with surgery alone remains undetermined.

Sections du résumé

BACKGROUND/OBJECTIVES OBJECTIVE
Perineural invasion within keratinocyte cancer is a hallmark of tumour aggression, and a definitive treatment paradigm for this condition remains undetermined. Our aim was to investigate the treatment and outcomes of keratinocyte cancer with incidental perineural invasion within two skin cancer databases to refine treatment protocols.
METHODS METHODS
We retrospectively assessed the Queensland Perineural Invasion Registry for surgery, histopathology, adjuvant radiotherapy and recurrence of keratinocyte cancer five years post-definitive treatment. We also reviewed the Princess Alexandra Hospital Head and Neck clinical perineural invasion database, specifically looking at surgical margins and adjuvant radiotherapy of cutaneous squamous cell carcinoma (cSCC) with incidental perineural invasion in the primary lesion.
RESULTS RESULTS
There was no recurrence at 5 years in the Perineural Invasion Registry. Basal cell carcinoma (BCC) lesions with nerves <0.1 mm were more commonly treated with surgery alone, compared to lesions with nerves ≥0.1 mm which were offered adjuvant radiotherapy. Of the total BCC lesions with incidental perineural invasion, those with perineural margins ≥5 mm and peripheral tumour margins ≥3 mm were predominantly treated with surgery alone. Eighty-nine per cent of cSCC lesions with incidental perineural invasion were treated with surgery and adjuvant radiotherapy.
CONCLUSION CONCLUSIONS
Surgery alone is suitable for BCC lesions with incidental perineural invasion. The majority of BCC lesions achieved ≥5 mm perineural and ≥3 mm peripheral tumour margins. Future research can guide if adjuvant radiation is required for BCC with perineural invasion. The treatment of cSCC with incidental perineural invasion with surgery alone remains undetermined.

Identifiants

pubmed: 32285436
doi: 10.1111/ajd.13290
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

226-230

Informations de copyright

© 2020 The Australasian College of Dermatologists.

Références

Fransen M, Karahalios A, Sharma N et al. Non-melanoma skin cancer in Australia. Med. J. Aust. 2012; 197: 565-8.
Buchanan L, De'Ambrosis B, DeAmbrosis K et al. Defining incidental perineural invasion: the need for a national project. Australas J. Dermatol. 2014; 55: 107-110.
Gupta A, Veness M, De'Ambrosis B et al. Management of squamous cell and basal cell carcinomas of the head and neck with perineural invasion. Australas J. Dermatol. 2016; 57: 3-13.
Jackson JE, Dickie GJ, Wiltshire KL et al. Radiotherapy for perineural invasion in cutaneous head and neck carcinomas: towards a risk-adapted treatment approach. Head Neck 2009; 31: 604-10.
Leibovitch I, Huilgol SC, Selva D et al. Basal cell carcinoma treated with Mohs surgery in Australia III. perineural invasion. J. Am. Acad. Dermatol. 2005; 53: 458-63.
Lin C, Tripcony L, Keller J et al. Perineural infiltration of cutaneous squamous cell carcinoma and basal cell carcinoma without clinical features. Int. J. Radiat. Oncol. Biol. Phys. 2012; 82: 334-40.
Miller ME, Palla B, Chen Q et al. A novel classification system for perineural invasion in non-cutaneous head and neck squamous cell carcinoma: histologic subcategories and patient outcomes. Am. J. Otolaryngol. 2012; 33: 212-5.
Yu W, Yun YK, Whang I et al. The Surgeon’s Expertise-Outcome relationship in gastric cancer surgery. Cancer Res. Treat. 2005; 37: 143-147.
Panizza B, Warren TA, Solares CA et al. Histopathological features of clinical perineural invasion of cutaneous squamous cell carcinoma of the head and neck and the potential implications for treatment. Head Neck 2014; 36: 1611-1618.
Warren TA, Whiteman DC, Porceddu SV et al. Insight into the epidemiology of cutaneous cell carcinoma with perineural spread. Head Neck 2016; 38: 1416-20.

Auteurs

Agnieszka Adams (A)

University of Queensland, St Lucia, Queensland, Australia.
School of Medicine, University of Queensland, Herston, Queensland, Australia.
QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.

Brian De'Ambrosis (B)

University of Queensland, St Lucia, Queensland, Australia.
South East Dermatology, Annerley, Queensland, Australia.
Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.

Ben Panizza (B)

Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.

Paul Belt (P)

Greenslopes Private Hospital, Greenslopes, Queensland, Australia.

James Emmett (J)

Morris Towers Morris, Spring Hill, Queensland, Australia.

Tim Warren (T)

School of Medicine, University of Queensland, Herston, Queensland, Australia.

David C Whiteman (DC)

QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH